Anti-cold drug combination banned for kids under 4 years: All you need to know

The use of an anti-cold fixed drug combination has been prohibited by the Indian drugs regulator Central Drugs Standard Control Organisation (CDSCO) to be used for children under the age of 4.

This common cold fixed drug combination (FDC) is a cocktail of two drugs, chlorpheniramine maleate and phenylephrine.

This decision was made based on the recommendations of the Subject Expert Committee (SEC) which emphasised that this drug combination should not be used for children below four years of age.All manufacturers of this common cold fixed-dose combination (FDC), containing chlorpheniramine maleate IP 2mg with phenylephrine HCL IP 5 mg per ml drops, have been directed to include a warning on the label and the package about the caution: “FDC should not be used in children below 4 years of age.”The order by the regulator on the fixed-drug combination was issued on December 18 and made public on Wednesday.

All about this anti-cold fixed drug combination

This anti-cold drug combination contains chlorpheniramine maleate and phenylephrine. While chlorpheniramine maleate is an anti-allergic drug (antihistamine), phenylephrine is a decongestant.

According to Cleveland Clinic, this drug combination helps treat symptoms of common cold or sinus inflammation. It can help relieve runny nose, sneezing and congestion in the nose. However, this medicine will not treat an infection.n case you’re consuming this drug formulation, do not increase the recommended dose as it could result in serious harm such as hallucinations, seizure and death,

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!